# H7N9 Mix and Match With AS03 and MF59 in Healthy Adults

> **NCT01942265** · PHASE2 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 980 (actual)

## Conditions studied

- Influenza

## Interventions

- **DRUG:** AS03
- **DRUG:** MF59
- **BIOLOGICAL:** Influenza Virus Vaccine, Monovalent A/H7N9 A/Shanghai/2/2013

## Key facts

- **NCT ID:** NCT01942265
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-09
- **Primary completion:** 2015-01
- **Final completion:** 2015-01
- **Target enrollment:** 980 (ACTUAL)
- **Last updated:** 2017-07-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01942265

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01942265, "H7N9 Mix and Match With AS03 and MF59 in Healthy Adults". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01942265. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*